Essential Fatty Acid (EFA) Nutrition 5-Year-Olds X Section
NCT01112930 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 187
Last updated 2015-04-15
Summary
In humans, docosahexanoic acid (DHA) is concentrated in brain. After birth, DHA is obtained from breast milk or the child's diet. The investigators are studying whether DHA intakes in young children are adequate to support brain development. This is a cross-sectional study of children 5-6 years-old.
Conditions
- Breastfeeding
Sponsors & Collaborators
-
Canadian Institutes of Health Research (CIHR)
collaborator OTHER_GOV -
University of British Columbia
lead OTHER
Principal Investigators
-
Sheila M. Innis, Dr. · University of British Columbia
-
Tim Oberlander, MD · University of British Columbia
Eligibility
- Min Age
- 5 Years
- Max Age
- 6 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2010-02-28
- Primary Completion
- 2014-11-30
- Completion
- 2014-11-30
Countries
- Canada
Study Locations
More Related Trials
-
DHA Supplementation for Lactating Mothers
NCT01732874 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Investigating the Effects of Nutrition on the Maturation of Brain Networks Associated With Memory in Infants
NCT02457078 ·Status: UNKNOWN ·Phase: NA
-
N-3 Fatty Acid Requirements for Human Development
NCT00620672 ·Status: COMPLETED ·Phase: PHASE1
-
Effect of Fish Oil on Athlete's Executive Function
NCT04570995 ·Status: TERMINATED ·Phase: NA
-
Prenatal DHA and Neurofunctional Development
NCT02709239 ·Status: COMPLETED ·Phase: NA
-
Behavioral, Genetic, and Epigenetic Implications of Dietary Supplementation With Alpha-linolenic Acid in Humans
NCT01634776 ·Status: COMPLETED ·Phase: NA
-
Growth and Adiposity in Newborns: The Influence of Prenatal Docosahexaenoic Acid (DHA) Supplementation
NCT03310983 ·Status: COMPLETED
-
Fatty Acids and Executive Function Development in 7-12 Year Olds
NCT02199808 ·Status: COMPLETED
-
PUFA Supplementation in Premature Infants
NCT01955044 ·Status: COMPLETED ·Phase: NA
-
Effect of DHA on Proinflammatory Cytokines Including Platelets Activating Factor (PAF) in Preterm Neonates
NCT04746885 ·Status: COMPLETED ·Phase: NA
-
Arachidonic Acid Supplementation in Very Preterm Infants
NCT02503020 ·Status: COMPLETED ·Phase: PHASE2
-
LCPUFA Supplementation: A Multi-Modality Imaging Study
NCT02076048 ·Status: COMPLETED
-
Effects of Docosahexaenoic Acid (DHA) on Fetal Cardiac Outcomes
NCT01007110 ·Status: COMPLETED ·Phase: PHASE3
-
Fish Oil Brain Delivery Study
NCT02541929 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
A Randomized Clinical Trial on Supplementation of DHA and AA to Preterm Infants
NCT00226187 ·Status: COMPLETED ·Phase: NA
-
Bioavailability of Different Formulas Enriched With DHA Using Wet Mixing or Dry Blending Method
NCT04460287 ·Status: COMPLETED ·Phase: NA
-
Metabolic Mechanisms Induced by Enteral DHA and ARA Supplementation in Preterm Infants
NCT05380401 ·Status: RECRUITING ·Phase: NA
-
Fish Oil Supplementation in Lactation
NCT00266305 ·Status: COMPLETED ·Phase: NA
-
Effect of Docosahexaenoic Acid (DHA)-Enriched Human Milk in Premature Newborns
NCT01062373 ·Status: TERMINATED ·Phase: NA
-
Cognitive and Mood Effects of Docosahexaenoic Acid (DHA)-Rich and Eicosapentaenoic Acid (EPA)-Rich Fish Oil in Healthy Young Adults
NCT01075919 ·Status: COMPLETED ·Phase: NA
-
Polyunsaturated Fatty Acids (PUFA) Status and Cognitive Function in Healthy Young Adults
NCT01075958 ·Status: COMPLETED
-
Essential Fatty Acids During Complementary Feeding
NCT00631046 ·Status: COMPLETED ·Phase: NA
-
Effects of Omega-3 Fatty Acids Supplement in Cognition of Young Healthy Adults and in Their Reaction Time of Computerized Test After 3 Months of Taking High-concentrated DHA and EPA Fish Softgels
NCT03781557 ·Status: UNKNOWN ·Phase: PHASE4
-
The Effects of Omega-3 PUFAs on the Infant Microbiome and Immunity
NCT03297801 ·Status: COMPLETED
-
Polyunsaturated Fatty Acids in Child Nutrition
NCT01487889 ·Status: COMPLETED ·Phase: NA